top of page

News

July 8, 2024

XMS Capital Partners Expands UK Footprint with FinTech and Financial Services Focus

XMS Capital Partners LLC (“XMS”), a global, independent financial services firm focused on providing M&A, corporate advisory and asset management services, is pleased to announce the expansion of its UK business with a focus on FinTech and Financial Services.

July 1, 2024

XMS Capital Partners Serves as Exclusive Financial Advisor to StatRad on its Sale to I-MED

XMS Capital Partners, LLC (“XMS”), a global, independent financial services firm focused on providing M&A, corporate advisory and asset management services, announced that it served as financial advisor to StatRad LLC (“StatRad” or the “Company”) on its sale to I-MED, an Australia-based radiology provider.

January 24, 2024

XMS Expands Industrial Sector Coverage in Automotive and Packaging with Two Managing Director Hires

XMS Capital Partners LLC (“XMS”), a global, independent financial services firm focused on providing M&A, corporate advisory and asset management services, is pleased to announce the additions of Christopher Blake and Todd VanderMolen to the firm as Managing Directors.

Dec 15, 2023

XMS Capital Partners Serves as Exclusive Financial Advisor to Bush Brothers Provision Company on its Partnership with Heartwood Partners

XMS Capital Partners, LLC (“XMS”), a global, independent financial services firm focused on providing M&A, corporate advisory and asset management services, announced that it served as financial advisor to Bush Brothers Provision Co. (“Bush Brothers” or the “Company”) on its majority investment with Heartwood Partners IV, LP (“Heartwood”), a middle market private equity firm. The investment was completed on July 7, 2023.

May 11, 2023

XMS Advised Babylon on its Sale of Higi to Modivcare

Higi, a digital health engagement company, is excited to announce that it has joined Modivcare Inc., a healthcare services company providing a suite of supportive care for public and private payors and their 34 million members.

Feb 23, 2023

XMS Advised Exact Sciences on its $573mm Debt Exchange Transaction and Private Placement of Convertible Senior Notes

Exact Sciences Corp. (Nasdaq: EXAS) (the "Company"), a leading provider of cancer screening and diagnostic tests, today announced that on February 23, 2023 it entered into a privately negotiated exchange and purchase agreement (the "Agreement") with a holder of certain of the Company's 0.3750% Convertible Senior Notes due 2027 (the "Existing 2027 Notes") and certain of its 0.3750% Convertible Senior Notes due 2028 (the "Existing 2028 Notes", and together with the "Existing 2027 Notes", the "Existing Notes").

August 2, 2022

XMS Advised Exact Sciences on the Sale of its Oncotype DX® GPS Prostate Cancer Business to Mdxhealth

MDxHealth SA (NASDAQ/Euronext: MDXH) ("mdxhealth" or the "Company"), a commercial-stage precision diagnostics company, today announced it has entered into an asset purchase agreement with Genomic Health, Inc., a subsidiary of Exact Sciences Corporation ("Exact Sciences"), to acquire the Oncotype DX® GPS (Genomic Prostate Score®) test from Exact Sciences along with most of its team of urology sales and marketing professionals.

July 19, 2022

XMS Advised Unity Aluminum on its Joint Venture Arrangement with Steel Dynamics

Steel Dynamics, Inc. (NASDAQ/GS: STLD) today announced that its Board of Directors has authorized the company to construct and operate a 650,000-tonne low-carbon, recycled aluminum flat rolled mill, with two supporting satellite recycled aluminum slab centers. The capital investment is estimated to be $2.2 billion for the three facilities, and commercial production is planned to begin in the first quarter 2025.

Jul 5, 2022

XMS Advised Aon on the Sale of its eDiscovery Practice to TCDI

TCDI, a leading provider of legal services, software and cybersecurity, today announced it completed the acquisition of global professional services firm Aon’s eDiscovery practice.

Jan 20, 2022

Core Scientific to Begin Trading on Nasdaq

Core Scientific, Inc. common stock and warrants to begin trading on the Nasdaq Stock Market under symbols “CORZ” and “CORZW” on January 20, 2022

Jan 09, 2022

Exact Sciences Acquires PreventionGenetics To Accelerate Availability Of Hereditary Cancer Testing For More Patients

PreventionGenetics' comprehensive genetic testing portfolio complements Exact Sciences' advanced cancer tests, enabling disease prevention and earlier cancer detection to benefit patients across decades of life. Foundational laboratory and skilled team with experience in sequencing, informatics, and genetic counseling will support entrance into hereditary cancer testing

Dec 01, 2021

RIOT BLOCKCHAIN ACQUIRES ESS METRON

Riot’s position as a vertically-integrated industry leader in Bitcoin mining significantly enhanced via the acquisition of ESS Metron, a premier provider of highly-engineered electrical equipment solutions

bottom of page